{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:41:53Z","timestamp":1792788113088,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":149,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the 2025 Government-funded Project for Cultivating Outstanding Clinical Medical Talents","award":["ZF2025220, ZF2025191"],"award-info":[{"award-number":["ZF2025220, ZF2025191"]}]},{"name":"the Natural Science Foundation program of Hebei","award":["H2024206074"],"award-info":[{"award-number":["H2024206074"]}]},{"name":"Medical Science Research Project of Hebei","award":["20240092"],"award-info":[{"award-number":["20240092"]}]},{"name":"Key Research and Development Program of Hebei","award":["22377791D"],"award-info":[{"award-number":["22377791D"]}]},{"name":"the Hebei Medical University \"14th Five-Year Plan\" Clinical Medicine Innovation Research Team Project","award":["2023LCTD-B6"],"award-info":[{"award-number":["2023LCTD-B6"]}],"id":[{"id":"https:\/\/ror.org\/04eymdx19","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-026-04300-8","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T11:25:05Z","timestamp":1776857105000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ASPM promotes the progression of esophageal squamous cell carcinoma by upregulating the expression of HMMR"],"prefix":"10.1186","volume":"26","author":[{"given":"Zhiruo","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangshuo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyuan","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"issue":"21","key":"4300_CR1","doi-asserted-by":"publisher","first-page":"9443","DOI":"10.7150\/thno.46078","volume":"10","author":"X ZHOU","year":"2020","unstructured":"ZHOU X, LI Y, WANG W, et al. Regulation of Hippo\/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2[J]. Theranostics. 2020;10(21):9443\u201357.","journal-title":"Theranostics"},{"issue":"13","key":"4300_CR2","doi-asserted-by":"publisher","first-page":"e34010","DOI":"10.1016\/j.heliyon.2024.e34010","volume":"10","author":"L Sun","year":"2024","unstructured":"Sun L, Ma K, Zhang S, Gu J, Wang H, Tan L. SENP2 promotes ESCC proliferation through SETDB1 deSUMOylation and enhanced fatty acid metabolism. Heliyon. 2024;10(13):e34010.","journal-title":"Heliyon"},{"issue":"10","key":"4300_CR3","doi-asserted-by":"publisher","first-page":"586","DOI":"10.21037\/atm-22-1112","volume":"10","author":"H Liu","year":"2022","unstructured":"Liu H, Zhou Q, Xu X, Du Y, Wu J. ASPM and TROAP gene expression as potential malignant tumor markers. Ann Transl Med. 2022;10(10):586.","journal-title":"Ann Transl Med"},{"issue":"1","key":"4300_CR4","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13059-025-03526-5","volume":"26","author":"X Jiang","year":"2025","unstructured":"Jiang X, Liu J, Wang K, Sun J, Yin H, Jiang Y, Liu Y, Wang N, Ding X, Gao P, Li L, Zhang X, Li J, Zhang R. ASPM mediates nuclear entrapment of FOXM1 via liquid-liquid phase separation to promote progression of hepatocarcinoma. Genome Biol. 2025;26(1):68.","journal-title":"Genome Biol"},{"issue":"6","key":"4300_CR5","doi-asserted-by":"publisher","first-page":"102534","DOI":"10.1016\/j.isci.2021.102534","volume":"24","author":"S XU","year":"2021","unstructured":"XU S, WU X, WANG P, et al. ASPM promotes homologous recombination-mediated DNA repair by safeguarding BRCA1 stability[J]. iScience. 2021;24(6):102534.","journal-title":"iScience"},{"issue":"18","key":"4300_CR6","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1158\/0008-5472.CAN-23-0158","volume":"83","author":"C TSAI K K, BAE B I, HSU C","year":"2023","unstructured":"TSAI K K, BAE B I, HSU C C, et al. Oncogenic ASPM Is a Regulatory Hub of Developmental and Stemness Signaling in Cancers[J]. Cancer Res. 2023;83(18):2993\u20133000.","journal-title":"Cancer Res"},{"issue":"6","key":"4300_CR7","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1158\/0008-5472.CAN-22-2496","volume":"83","author":"LH Cheng","year":"2023","unstructured":"Cheng LH, Hsu CC, Tsai HW, Liao WY, Yang PM, Liao TY, Hsieh HY, Chan TS, Tsai KK. ASPM Activates Hedgehog and Wnt Signaling to Promote Small Cell Lung Cancer Stemness and Progression. Cancer Res. 2023;83(6):830\u201344.","journal-title":"Cancer Res"},{"issue":"10","key":"4300_CR8","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.3324\/haematol.2012.065581","volume":"97","author":"S Snauwaert","year":"2012","unstructured":"Snauwaert S, Vanhee S, Goetgeluk G, Verstichel G, Van Caeneghem Y, Velghe I, Philipp\u00e9 J, Berneman ZN, Plum J, Taghon T, Leclercq G, Thielemans K, Kerre T, Vandekerckhove B. RHAMM\/HMMR (CD168) is not an ideal target antigen for immunotherapy of acute myeloid leukemia. Haematologica. 2012;97(10):1539\u201347.","journal-title":"Haematologica"},{"issue":"3","key":"4300_CR9","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/path.6082","volume":"260","author":"SE Tarullo","year":"2023","unstructured":"Tarullo SE, He Y, Daughters C, Knutson TP, Henzler CM, Price MA, Shanley R, Witschen P, Tolg C, Kaspar RE, Hallstrom C, Gittsovich L, Sulciner ML, Zhang X, Forster CL, Lange CA, Shats O, Desler M, Cowan KH, Yee D, Schwertfeger KL, Turley EA, McCarthy JB, Nelson AC. Receptor for hyaluronan-mediated motility (RHAMM) defines an invasive niche associated with tumor progression and predicts poor outcomes in breast cancer patients. J Pathol. 2023;260(3):289\u2013303.","journal-title":"J Pathol"},{"issue":"6","key":"4300_CR10","doi-asserted-by":"publisher","first-page":"e18156","DOI":"10.1111\/jcmm.18156","volume":"28","author":"C Chen","year":"2024","unstructured":"Chen C, He Y, Ni Y, Tang Z, Zhang W. Identification of crosstalk genes relating to ECM-receptor interaction genes in MASH and DN using bioinformatics and machine learning. J Cell Mol Med. 2024;28(6):e18156.","journal-title":"J Cell Mol Med"},{"issue":"10","key":"4300_CR11","first-page":"2139","volume":"15","author":"SCM Q.Zhou","year":"2019","unstructured":"Q.Zhou SCM. Lu,et al.EFEMP2 suppresses epithelial-mesenchymal transition via Wnt\/beta-catenin signaling pathway in human bladder cancer Int. J Biol Sci. 2019;15(10):2139\u201355.","journal-title":"J Biol Sci"},{"issue":"5","key":"4300_CR12","doi-asserted-by":"publisher","first-page":"e24381","DOI":"10.1002\/jcla.24381","volume":"36","author":"H Shi","year":"2022","unstructured":"Shi H, Xu H, Chai C, Qin Z, Zhou W. Integrated bioinformatics analysis of potential biomarkers for pancreatic cancer. J Clin Lab Anal. 2022;36(5):e24381.","journal-title":"J Clin Lab Anal"},{"issue":"5","key":"4300_CR13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3892\/ijo.2021.5203","volume":"58","author":"J WANG","year":"2021","unstructured":"WANG J, LIANG J, LI H, et al. Oncogenic role of abnormal spindle\u2013like microcephaly\u2013associated protein in lung adenocarcinoma[J]. Int J Oncol. 2021;58(5):23.","journal-title":"Int J Oncol"},{"issue":"3","key":"4300_CR14","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s11912-021-01153-4","volume":"24","author":"WATERS J K","year":"2022","unstructured":"WATERS J K. REZNIK S I. Update on Management of Squamous Cell Esophageal Cancer[J]. Curr Oncol Rep. 2022;24(3):375\u201385.","journal-title":"Curr Oncol Rep"},{"key":"4300_CR15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/bs.acr.2019.05.004","volume":"144","author":"R REICHENBACH Z W, MURRAY M G, SAXENA","year":"2019","unstructured":"REICHENBACH Z W, MURRAY M G, SAXENA R, et al. Clinical and translational advances in esophageal squamous cell carcinoma[J]. Adv Cancer Res. 2019;144:95\u2013135.","journal-title":"Adv Cancer Res"},{"issue":"6","key":"4300_CR16","first-page":"394","volume":"68","author":"F BRAY","year":"2018","unstructured":"BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4300_CR17","doi-asserted-by":"publisher","first-page":"224","DOI":"10.18632\/aging.102612","volume":"12","author":"X CHEN","year":"2020","unstructured":"CHEN X, HUANG L, YANG Y, et al. ASPM promotes glioblastoma growth by regulating G1 restriction point progression and Wnt-\u03b2-catenin signaling[J]. Aging(Albany NY).2020;12(1):224\u201341.","journal-title":"Aging"},{"issue":"8","key":"4300_CR18","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1038\/s41388-018-0497-4","volume":"38","author":"VC Pai","year":"2019","unstructured":"Pai VC, Hsu CC, Chan TS, Liao WY, Chuu CP, Chen WY, Li CR, Lin CY, Huang SP, Chen LT, Tsai KK. ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-\u03b2-catenin signaling. Oncogene. 2019;38(8):1340\u201353.","journal-title":"Oncogene"},{"issue":"5","key":"4300_CR19","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s11255-017-1545-7","volume":"49","author":"JJ XIE","year":"2017","unstructured":"XIE JJ, ZHUO Y J, ZHENG Y, et al. High expression of ASPM correlates with tumor progression and predicts poor outcome in patients with prostate cancer[J]. Int Urol Nephrol. 2017;49(5):817\u201323.","journal-title":"Int Urol Nephrol"},{"key":"4300_CR20","doi-asserted-by":"publisher","first-page":"1720799","DOI":"10.3389\/fimmu.2025.1720799","volume":"16","author":"R Chen","year":"2025","unstructured":"Chen R, Wang S, Xie J. PSMD14 drives lung adenocarcinoma progression through HMMR stabilization and dual activation of TGF-\u03b2\/Smad and PI3K\/AKT\/mTOR signaling. Front Immunol. 2025;16:1720799.","journal-title":"Front Immunol"},{"issue":"46","key":"4300_CR21","doi-asserted-by":"publisher","first-page":"17402","DOI":"10.1073\/pnas.0608396103","volume":"103","author":"S Horvath","year":"2006","unstructured":"Horvath S, Zhang B, Carlson M, et al. Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target [J]. Proc Natl Acad Sci USA. 2006;103(46):17402\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"23","key":"4300_CR22","doi-asserted-by":"publisher","first-page":"eadl6083","DOI":"10.1126\/sciadv.adl6083","volume":"10","author":"H Wu","year":"2024","unstructured":"Wu H, Liu Y, Liu Q, et al. HMMR triggers immune evasion of hepatocellular carcinoma by inactivation of phagocyte killing. Sci Adv. 2024;10(23):eadl6083.","journal-title":"Sci Adv"},{"issue":"2","key":"4300_CR23","first-page":"1865","volume":"17","author":"Z Xu","year":"2019","unstructured":"Xu Z, Zhang Q, Luh F, Jin B, Liu X. Overexpression of the ASPM gene is associated with aggressiveness and poor outcome in bladder cancer. Oncol Lett. 2019;17(2):1865\u201376.","journal-title":"Oncol Lett"},{"issue":"5","key":"4300_CR24","first-page":"1942","volume":"12","author":"JW Zhou","year":"2020","unstructured":"Zhou JW, Wang H, Sun W, Han NN, Chen L. ASPM is a predictor of overall survival and has therapeutic potential in endometrial cancer. Am J Transl Res. 2020;12(5):1942\u201353.","journal-title":"Am J Transl Res"},{"issue":"17","key":"4300_CR25","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.7150\/jca.88063","volume":"14","author":"Z Cao","year":"2023","unstructured":"Cao Z, Li Y, Xu C, Zhang Z, Wang Z, Ma Z, Xu P, Sun X, He X, Zhang J, Jiang H, Li G. Activation of assembly factor for spindle microtubules triggers progression of renal cell carcinoma via Wnt3a pathway. J Cancer. 2023;14(17):3248\u201357.","journal-title":"J Cancer"},{"issue":"4","key":"4300_CR26","doi-asserted-by":"publisher","first-page":"687","DOI":"10.21037\/gs-22-29","volume":"11","author":"Y Wu","year":"2022","unstructured":"Wu Y, You Y, Chen L, Liu Y, Liu Y, Lou W, Fu F. Abnormal spindle-like microcephaly-associated protein promotes proliferation by regulating cell cycle in epithelial ovarian cancer. Gland Surg. 2022;11(4):687\u2013701.","journal-title":"Gland Surg"},{"issue":"15","key":"4300_CR27","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.7150\/jca.88770","volume":"14","author":"J YUAN Y","year":"2023","unstructured":"YUAN Y J, SUN Y, GAO R, et al. Erratum: Abnormal spindle-like microcephaly-associated protein (ASPM) contributes to the progression of Lung Squamous Cell Carcinoma (LSCC) by regulating CDK4: Erratum[J]. J Cancer. 2023;14(15):2845\u20137.","journal-title":"J Cancer"},{"issue":"1","key":"4300_CR28","doi-asserted-by":"publisher","first-page":"80","DOI":"10.2174\/1568009620666200915090703","volume":"21","author":"J Wu","year":"2021","unstructured":"Wu J, He Z, Zhu Y, Jiang C, Deng Y, Wei B. ASPM Predicts Poor Clinical Outcome and Promotes Tumorigenesis for Diffuse Large B-cell Lymphoma. Curr Cancer Drug Targets. 2021;21(1):80\u20139.","journal-title":"Curr Cancer Drug Targets"},{"key":"4300_CR29","doi-asserted-by":"publisher","first-page":"4665","DOI":"10.2147\/OTT.S245681","volume":"13","author":"MAM YANG X X","year":"2020","unstructured":"YANG XX MAM, SANG MX, et al. Knockdown of FAM83D Enhances Radiosensitivity in Coordination with Irradiation by Inhibiting EMT via the Akt\/GSK-3\u03b2\/Snail Signaling Pathway in Human Esophageal Cancer Cells[J]. Onco Targets Ther. 2020;13:4665\u201378.","journal-title":"Onco Targets Ther"},{"issue":"7","key":"4300_CR30","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1002\/cbin.12012","volume":"47","author":"Q Fang","year":"2023","unstructured":"Fang Q, Li Q, Qi Y, Pan Z, Feng T, Xin W. ASPM promotes migration and invasion of anaplastic thyroid carcinoma by stabilizing KIF11. Cell Biol Int. 2023;47(7):1209\u201321.","journal-title":"Cell Biol Int"},{"issue":"5","key":"4300_CR31","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3892\/ijo.2021.5203","volume":"58","author":"J Wang","year":"2021","unstructured":"Wang J, Liang J, Li H, Han J, Jiang J, Li Y, Feng Z, Zhao R, Tian H. Oncogenic role of abnormal spindle-like microcephaly-associated protein in lung adenocarcinoma. Int J Oncol. 2021;58(5):23.","journal-title":"Int J Oncol"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-026-04300-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04300-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04300-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:02:07Z","timestamp":1789736527000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12935-026-04300-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4300"],"URL":"https:\/\/doi.org\/10.1186\/s12935-026-04300-8","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"22 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study received ethical approval from the Medical Ethics Committee of the Fouth Hospital of Hebei Medical University for the utilization of human specimens. All participants provided written informed consent prior to their involvement. Furthermore, all animal procedures were conducted in accordance with established ethical guidelines and were authorized by the Institutional Animal Care and Use Committee (IACUC) at the same institution.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Patient consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"318"}}